Close Menu

NEW YORK — A research team from the University of Colorado Cancer Center has received a $3 million grant from the National Cancer Institute to identify the genetic drivers of aggressive prostate cancer.

With the five-year grant, CU Cancer Center's James Costello and colleagues will knock out various prostate cancer-associated genes in a mouse model and identify which develop aggressive disease. RNA sequencing will be used to compare and contrast the gene expression and pathways between the models. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.